Company news

iBio, Inc. news in 2024

iBio, Inc.'s news releases, calls and decks from 2024, newest first.

View company

iBio Strengthens Board with Appointment of Two New Independent Directors

November 24, 2024

iBio Reports Fiscal First Quarter 2025 Financial Results

November 11, 2024

iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

September 19, 2024

iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development

August 11, 2024

iBio Closes Sale of Manufacturing Facility in Texas

June 2, 2024

iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update

May 12, 2024

iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases

March 26, 2024

iBio Announces $15.0 Million Private Placement

March 25, 2024

iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka

February 25, 2024

iBio Announces Participation in 23rd Annual PepTalk Conference

January 15, 2024

Decks in 2024